From Medscape Ophthalmology

European Society of Retina Specialists (EURETINA) 2020

October 02 - 04, 2020; VIRTUAL

October 02 - 04, 2020 VIRTUAL

EURETINA 2020 Changes to Anti-VEGF Protocols Questioned in Wet AMD
Medscape Medical News, October 14, 2020
EURETINA 2020 Implant Reduces Treatment Burden in Wet Macular Degeneration
Medscape Medical News, October 13, 2020
EURETINA 2020 Dexamethasone for Macular Edema Unresponsive to Anti-VEGF
Medscape Medical News, October 9, 2020

Medscape Ophthalmology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Related Ophthalmology News

NAMD Patients With More Fluctuation in Retinal Thickness Have Poorer Anti-VEGF Outcomes Greater fluctuation in retinal thickness in patients with neovascular age-related macular degeneration portends poorer outcomes of anti-VEGF treatment.
Medscape Medical News, Aug 31, 2020
Macular Edema Treatments Less Effective in the Real World Anti-VEGF drugs preserved vision in patients treated for diabetic macular edema after 5 years, but not as well as when the patients were part of a clinical trial.
Medscape Medical News, Aug 18, 2020
Cardio Risk Increases With Diabetic Retinopathy Progression The strong correlation between severity of diabetic retinopathy and cardiovascular events could help ophthalmologists motivate affected patients with type 2 diabetes to see a primary care provider.
Medscape Medical News, Aug 03, 2020

Related Resource